Every two years, doctors specialising in breast cancer gather in St Gallen to discuss developments and update guidelines on adjuvant therapies. It is always an important conference, but its conclusions tend to be measured rather than headline grabbing.
Related Articles
Impact Factor
Neoadjuvant trial design: time for a brave new world?
Senza categoria
Newsround
Spotlight on